MRSH trades 20.9% below analyst target ahead of Q3
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Marsh & McLennan stock is facing a Q3 test following its acquisition of Accel Holdings, which expands its insurance and advisory capabilities in the Upper Midwest. The company will report third-quarter results on October 15, 2026, with analysts anticipating increased earnings per share and revenue. JPMorgan has maintained an Overweight rating and raised its price target for the stock.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.